Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. medical protective
Show results for
Products
Services
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Medical Protective Articles & Analysis

37 news found

Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Phenylpropanoids are explored for their potential as antioxidants, UV protectants, and anti-inflammatory agents. Their versatility extends to applications in cancer treatment and wound healing, making them a significant focus of biotechnological research. ...

ByAlfa Chemistry


EMI/RFI: Materials and Technologies - A Comprehensive Market Analysis by BCC Research

EMI/RFI: Materials and Technologies - A Comprehensive Market Analysis by BCC Research

Boston: “According to the latest BCC Research study, the demand for EMI/RFI: Materials and Technologies is estimated to increase from $7.4 billion in 2023 to reach $9.2 billion by 2028, at a compound annual growth rate (CAGR) of 4.6% from 2023 through 2028.” This comprehensive report delves into the dynamic landscape of the EMI/RFI materials and technologies market, meticulously ...

ByBCC Research


FARCO-PHARMA supports “Protect the vulnerable“

FARCO-PHARMA supports “Protect the vulnerable“

Furthermore, they usually need additional assistance and nursing, which is why ESCIF initiated a unique project to protect this vulnerable group. The organization aims to supply the people affected in 28 European countries with free medical mouth-nose-protection for their caregivers as a form of external protection. Over the next ...

ByFARCO-PHARMA GmbH


BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

Animals in all treatment groups experienced significantly less weight loss compared with the placebo group at day 6 (p “Given the simplicity of this therapeutic modality and prior research with similar antibodies we were expecting to see positive results here, but we were happily surprised to observe such robust protection right off the bat,” said Craig Behnke, EVP ...

ByLumen Bioscience, Inc.


Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

Currently, there is a paucity of effective treatments to address this unmet medical need. NHT has a patent-protected inhalation device technology (DryNeb) capable of delivering high therapeutic doses directly to the infected area in the lung. ...

ByNob Hill Therapeutics


Micropore, Inc. 2020 Champion of Maryland Manufacturing

Micropore, Inc. 2020 Champion of Maryland Manufacturing

Micropore is working to innovate filtration for ventilators and other medical and clinical applications in an effort to support the response to the COVID-19 pandemic. ...

BySpiraLith Brand of Micropore, Inc.


Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

In addition to SER-109, SER-155 represents Seres’ second active development program in its Infection Protection franchise. Another poster presentation on June 4 at 1:15-4:15 PM CDT will reprise Phase III trial results of SER-109, an investigational microbiome therapeutic for recurrentC.difficileinfection (rCDI). ...

BySeres Therapeutics, Inc.


Seres Therapeutics Presents Phase III Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Seres Therapeutics Presents Phase III Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

“These findings suggest that the first two weeks following antibiotic treatment is the time when microbiome therapeutics have the greatest potential benefit, by restoring bacterial diversity and disrupting the cycle of recurrent C. difficile,” said Lisa von Moltke, M.D., Chief Medical Officer at Seres. SER-109 introduces a diverse consortium of bacterial species into ...

BySeres Therapeutics, Inc.


Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

The results will be presented in detail at a second dedicated session ‘Robotic PCI: Evolution or R-Evolution’ on Thursday May 19, in room 251 between 12:15 and 1:00 p.m. (CET). R-One is a medical robot specifically designed to perform coronary angioplasties (stent implantation). ...

ByRobocath


Seres Therapeutics Presents Preclinical Research on Investigational Microbiome Therapeutic SER-155 at the 2022 European Bone Marrow Transplantation Annual Meeting

Seres Therapeutics Presents Preclinical Research on Investigational Microbiome Therapeutic SER-155 at the 2022 European Bone Marrow Transplantation Annual Meeting

“Microbiome-based therapeutics have the potential to protect medically compromised transplant patients from life-threatening infections and GvHD as they start on their road to recovery,” said Matthew Henn, PhD, Chief Scientific Officer at Seres and co-author. ...

BySeres Therapeutics, Inc.


Seres Therapeutics to Present Data on Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Seres Therapeutics to Present Data on Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

“We are eager to showcase new data that further validate the potential of our investigational microbiome therapeutic, SER-109, at the world’s largest gathering of physicians and researchers in the digestive disease field,” said Lisa von Moltke, M.D., Chief Medical Officer at Seres. “These data reinforce our strongly-held belief in the power of the ...

BySeres Therapeutics, Inc.


Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

Seres continues to execute pre-commercialization activities in collaboration with Aimmune Therapeutics, including market education and data dissemination to the medical community. Medical Affairs led engagement of key opinion leaders has increased following the publication of the SER-109 Phase 3 data in theNew England Journal of Medicine. ...

BySeres Therapeutics, Inc.


INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that several volunteers have been dosed with its DNA-based, intradermal Ebola vaccine candidate, INO-4201, as part of a randomized, placebo-controlled, Phase 1b ...

ByINOVIO Pharmaceuticals


Enalare Therapeutics Invited to Present at BARDA Industry Day 2021

Enalare Therapeutics Invited to Present at BARDA Industry Day 2021

Department of Health and Human Services and is focused on the development of medical countermeasures to protect Americans and respond to 21st-century health security threats. ...

ByEnalare Therapeutics Inc.


Learn how you can Advocate for the Deaf  while Mask Mandates are in place

Learn how you can Advocate for the Deaf while Mask Mandates are in place

The CDC has advised that all students, teachers and school staff members in the U.S. wear medical grade face masks for optimum protection at school, regardless of vaccination status — while emphasizes that schools should still resume in-person learning. ...

BySafe’N’Clear, Inc.


Keeping medical environments safe, sterile, and protected from VOC exposure

Keeping medical environments safe, sterile, and protected from VOC exposure

Medical environments, whether that’s the development, manufacture or packing of pharmaceuticals and medical equipment, must be monitored to the highest levels to ensure complete compliance and safety for staff and end-users. ION Science’s range of fixed PID sensors can measure VOC outputs on multiple large sites or single key areas, using world-leading gas detection technology. One ...

ByION Science Ltd.


Riello UPS supports Emergency’s new children’s hospital

Riello UPS supports Emergency’s new children’s hospital

For this reason Riello UPS participated with great enthusiasm in the project and donated a number of UPSs to protect the most strategic areas of the building: the operating theaters were equipped with 2 60 kVA Multi Sentry MSTs installed in parallel with an autonomy of 60 minutes; the analysis laboratories and related computer systems were protected with a 125 ...

ByRiello UPS Spa


CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

CardiacSense – a digital health company that developed and clinically verified a medical grade watch capable of detecting and remotely monitoring Atrial Fibrillation (A-Fib) and Heart Rate Variability (HRV) announced that it received the CE Mark for marketing & sales of the device in the European Union. ...

ByCardiacSense


Protecting Patients and Medical Staff from Healthcare-Associated Mold Outbreaks in Puerto Rico

Protecting Patients and Medical Staff from Healthcare-Associated Mold Outbreaks in Puerto Rico

Many patients treated in hospitals or staying in long-term care facilities have conditions that make them much more susceptible to infections due to microbial pathogens, including mold. Over the past last several years, a number of hospitals across the United States have had to temporarily close portions of their facilities due to the discovery of mold growth. In a high profile case in ...

ByZimmetry Environmental


IMBDx to Attend Bio Health Worldwide Online 2020

IMBDx to Attend Bio Health Worldwide Online 2020

Over 500 companies in the fields of biotechnology, pharmaceutical, medical device, healthcare, dietary supplements, and protective supplies, as well as over 1,000 potential buyers from all over the world, are expected to attend. ...

ByIMB Dx, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT